Consumer Automotive Finance, Inc.
Finalizes Agreement to Retire 246 Million Common
Shares:
Strategic Move Signals Robust
Commitment to Shareholder Value Enhancement
Melbourne, FL --
February 25, 2025 -- InvestorsHub NewsWire -- Consumer Automotive
Finance, Inc. (OTCPK:
CAFI), a dynamic leader in the sports supplement, fitness
equipment, and health and wellness industries, proudly announces
the finalization of an agreement to retire 246 million of its
issued and outstanding common shares. This transformative action,
executed with precision by the company's management team,
underscores an unwavering dedication to fortifying shareholder
value and optimizing its capital structure as it continues to
thrive on the OTC market.
The retirement of
these 246 million shares, a significant step in CAFI's ongoing
strategic evolution, is anticipated to be reflected on the OTC
Markets website within the next 14 days, pending standard
procedural updates. This milestone follows the company's rigorous
efforts to streamline its equity framework, positioning CAFI to
deliver amplified returns and heightened stability for its investor
base.
A Bold Commitment to Shareholders
"This landmark
share retirement exemplifies our management team's resolute focus
on creating enduring value for our shareholders," stated Brandon
Spikes, Chairman of Consumer Automotive Finance, Inc. "By reducing
our outstanding shares by 246 million, we are not only enhancing
the intrinsic value of each remaining share but also signaling our
confidence in CAFI's growth trajectory and long-term profitability.
This is a deliberate, shareholder-centric strategy designed to
reward those who have invested in our vision."
The decision to
retire such a substantial portion of common stock reflects CAFI's
proactive approach to capital management, a cornerstone of its
operational philosophy. By decreasing the total share count, the
company aims to bolster earnings per share potential, elevate
market perception, and provide a stronger foundation for future
growth initiatives—all while maintaining its commitment to
transparency and compliance as an OTC-traded entity. Importantly,
this retirement marks merely the first step in a broader
initiative, as CAFI's leadership is committed to continuously
exploring additional avenues to enhance shareholder value, further
tighten the share structure, and uphold the highest standards of
transparency with its investors. "This is only the beginning,"
Spikes emphasized. "We will persist in identifying innovative
strategies to refine our equity framework and ensure our
shareholders remain at the heart of every decision."
Transition to Fifty 1 Labs, Inc.: A Milestone
Achievement with FINRA Approval
In a momentous
development, Consumer Automotive Finance, Inc. is poised to rebrand
as Fifty 1 Labs, Inc., with its shares soon to trade under the
ticker symbol "FITY" on the OTC market. This transition follows the
successful completion of an exhaustive review process by the
Financial Industry Regulatory Authority (FINRA), a rigorous
undertaking that spanned an extended period and entailed a
comprehensive examination of the company's historical records,
financial books, and operational legacy. "Navigating FINRA's
meticulous inquiry was a formidable challenge, yet it reflects our
commitment to the highest standards of diligence and
accountability," Spikes noted. "This approval marks a profound
validation of our corporate integrity and positions Fifty 1 Labs,
Inc. as a fortified entity ready to lead with renewed clarity and
purpose." Shareholders can anticipate this rebranding to further
enhance the company's market identity and investor appeal.
Enhancing Value in a Competitive
Market
Operating within
the rapidly expanding health and wellness sector, CAFI—soon to be
Fifty 1 Labs, Inc.—continues to leverage its diversified portfolio,
including its flagship "51" sports supplement brand and
subsidiaries like 51 Labs and The Quickness, to capture market
opportunities. The share retirement aligns seamlessly with these
efforts, demonstrating to investors that management is not merely
content with operational success but is actively sculpting a
financial structure that maximizes shareholder equity.
"Our leadership
team views this share retirement as a pivotal lever to unlock
value," Spikes added. "It's a clear message to our shareholders: we
are here to build a legacy of trust, performance, and prosperity.
By reducing our share float, we enhance the scarcity and potential
appreciation of CAFI stock, ensuring that our investors reap the
rewards of our strategic foresight."
A Future Built on Shareholder Trust
This action builds
on CAFI's history of shareholder-friendly initiatives, including
prior share reductions and its ongoing pursuit of an uplisting to
the OTCQB market tier. The retirement of 246 million shares,
coupled with the forthcoming transition to Fifty 1 Labs, Inc., is a
testament to the management team's meticulous stewardship,
balancing aggressive growth with prudent financial discipline. As
the company anticipates the share retirement update on the OTC
Markets website within the next two weeks, it reaffirms its pledge
to keep investors informed through timely disclosures and robust
communication channels.
Consumer Automotive
Finance, Inc., soon to be Fifty 1 Labs, Inc., remains steadfast in
its mission to deliver cutting-edge products and unparalleled
value, both in the marketplace and to its shareholders. With these
strategic advancements, CAFI solidifies its position as a
forward-thinking public company poised for sustained success on the
OTC market.
For additional
updates, investors and stakeholders are encouraged to visit the
company's official website https://fifty1labs.com/
or follow CAFI on X https://x.com/Fifty1Labs.
This is Consumer Automotive Finance, Inc.—where innovation meets
investor empowerment.
About Fifty 1 Labs, Inc.
Consumer Automotive
Finance, Inc. (OTCPK: CAFI), soon to be renamed Fifty 1 Labs, Inc.,
is a publicly traded company focused on sports supplementation,
fitness equipment, and holistic wellness. The company operates four
key subsidiaries: 51, LLC, which specializes in sports supplements;
The Quickness, which offers patented athletic training equipment;
Astound NMN, a leader in anti-aging and DNA repair supplements; and
Drago Knives, patented knife throwing technology. Fifty 1 Labs,
Inc. is also actively pursuing strategic acquisitions to expand its
portfolio and drive sustainable growth.
Safe Harbor
Statement:
The information
provided in this release may contain forward-looking statements
within the meaning of the Private Securities Litigation Reform Act
of 1995. Identifiable by words such as "may," "will," "should,"
"plans," "expects," "anticipates," "continue," "estimate,"
"project," "intend," and similar expressions, these statements may
also be made in written or oral form in the company's filings with
the U.S. Securities and Exchange Commission, OTC Markets, press
releases, other written materials, or in oral statements made by
its officers, directors, or employees to third parties. There can
be no assurance that such statements will prove to be accurate. The
company cautions that these forward-looking statements are further
qualified by other factors including, but not limited to, those set
forth in the company's Disclosure Statements. Forward-looking
statements involve risks and uncertainties that could cause actual
results to differ materially from those projected or anticipated.
These risks and uncertainties include, but are not limited to,
general economic and business conditions, effects of continued
geopolitical unrest and regional conflicts, competition, changes in
technology and methods of marketing, delays in completing various
engineering and manufacturing programs, changes in customer order
patterns, changes in product mix, continued success in
technological advances and delivering technological innovations,
shortages in components, production delays due to performance
quality issues with outsourced components, and various other
factors beyond the company's control. The company does not
undertake any obligation to update publicly or to revise any
statements in this release, whether as a result of new information,
future events, or otherwise.
Investor Relations
Contact:
Investor
Relations
877-814-4188
ir@fifty1labs.com
